Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease

NCT00102115 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Degeneration
Choroidal Neovascularization

Interventions

DRUG: Talaporfin Sodium (LS11) Photodynamic Therapy (PDT)

Sponsor

Light Sciences LLC